British HIV Association (BHIVA) guidelines for the treatment of HIV-infected adults with antiretroviral therapy (2006)

B. Gazzard; E. J. Bernard; M. Boffito; D. Churchill; S. Edwards; M. Fisher; A. M. Geretti; M. Johnson; C. Leen; B. Peters; A. Pozniak; J. Ross; J. Walsh; E. Wilkins; M. Youle

doi:10.1111/j.1468-1293.2006.00424.x

British HIV Association (BHIVA) guidelines for the treatment of HIV-infected adults with antiretroviral therapy (2006)

B. Gazzard, E. J. Bernard, M. Boffito, D. Churchill, S. Edwards, M. Fisher, A. M. Geretti, M. Johnson, C. Leen, B. Peters, A. Pozniak, J. Ross, J. Walsh, E. Wilkins, M. Youle

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	487-503
Number of pages	16
Journal	HIV Medicine
Volume	7
Issue number	8
DOIs	https://doi.org/10.1111/j.1468-1293.2006.00424.x
Publication status	Published - Nov 2006

Keywords

methods: Antiretroviral Therapy, Highly Active
Disease Progression
Drug Resistance, Viral
Female
Great Britain
drug therapy: HIV Infections
administration & dosage: HIV Protease Inhibitors
Humans
therapeutic use: Integrase Inhibitors
Male
Patient Compliance
therapeutic use: Pyridazines
therapeutic use: Receptors, CCR5
administration & dosage: Reverse Transcriptase Inhibitors
Risk Assessment
therapeutic use: Sulfonamides

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1111/j.1468-1293.2006.00424.x

Cite this

Gazzard, B., Bernard, E. J., Boffito, M., Churchill, D., Edwards, S., Fisher, M., Geretti, A. M., Johnson, M., Leen, C., Peters, B., Pozniak, A., Ross, J., Walsh, J., Wilkins, E., & Youle, M. (2006). British HIV Association (BHIVA) guidelines for the treatment of HIV-infected adults with antiretroviral therapy (2006). HIV Medicine, 7(8), 487-503. https://doi.org/10.1111/j.1468-1293.2006.00424.x

@article{c993491c6fc94a378839267c25f7857e,

title = "British HIV Association (BHIVA) guidelines for the treatment of HIV-infected adults with antiretroviral therapy (2006)",

keywords = "methods: Antiretroviral Therapy, Highly Active, Disease Progression, Drug Resistance, Viral, Female, Great Britain, drug therapy: HIV Infections, administration & dosage: HIV Protease Inhibitors, Humans, therapeutic use: Integrase Inhibitors, Male, Patient Compliance, therapeutic use: Pyridazines, therapeutic use: Receptors, CCR5, administration & dosage: Reverse Transcriptase Inhibitors, Risk Assessment, therapeutic use: Sulfonamides",

author = "B. Gazzard and Bernard, {E. J.} and M. Boffito and D. Churchill and S. Edwards and M. Fisher and Geretti, {A. M.} and M. Johnson and C. Leen and B. Peters and A. Pozniak and J. Ross and J. Walsh and E. Wilkins and M. Youle",

year = "2006",

month = nov,

doi = "10.1111/j.1468-1293.2006.00424.x",

language = "English",

volume = "7",

pages = "487--503",

journal = "HIV Medicine",

issn = "1464-2662",

publisher = "John Wiley & Sons Ltd",

number = "8",

}

Gazzard, B, Bernard, EJ, Boffito, M, Churchill, D, Edwards, S, Fisher, M, Geretti, AM, Johnson, M, Leen, C, Peters, B, Pozniak, A, Ross, J, Walsh, J, Wilkins, E & Youle, M 2006, 'British HIV Association (BHIVA) guidelines for the treatment of HIV-infected adults with antiretroviral therapy (2006)', HIV Medicine, vol. 7, no. 8, pp. 487-503. https://doi.org/10.1111/j.1468-1293.2006.00424.x

TY - JOUR

T1 - British HIV Association (BHIVA) guidelines for the treatment of HIV-infected adults with antiretroviral therapy (2006)

AU - Gazzard, B.

AU - Bernard, E. J.

AU - Boffito, M.

AU - Churchill, D.

AU - Edwards, S.

AU - Fisher, M.

AU - Geretti, A. M.

AU - Johnson, M.

AU - Leen, C.

AU - Peters, B.

AU - Pozniak, A.

AU - Ross, J.

AU - Walsh, J.

AU - Wilkins, E.

AU - Youle, M.

PY - 2006/11

Y1 - 2006/11

KW - methods: Antiretroviral Therapy, Highly Active

KW - Disease Progression

KW - Drug Resistance, Viral

KW - Female

KW - Great Britain

KW - drug therapy: HIV Infections

KW - administration & dosage: HIV Protease Inhibitors

KW - Humans

KW - therapeutic use: Integrase Inhibitors

KW - Male

KW - Patient Compliance

KW - therapeutic use: Pyridazines

KW - therapeutic use: Receptors, CCR5

KW - administration & dosage: Reverse Transcriptase Inhibitors

KW - Risk Assessment

KW - therapeutic use: Sulfonamides

U2 - 10.1111/j.1468-1293.2006.00424.x

DO - 10.1111/j.1468-1293.2006.00424.x

M3 - Article

SN - 1464-2662

VL - 7

SP - 487

EP - 503

JO - HIV Medicine

JF - HIV Medicine

IS - 8

ER -